Elbow Artery Embolization for Tennis Elbow

NARecruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

March 21, 2023

Primary Completion Date

March 1, 2026

Study Completion Date

January 1, 2027

Conditions
Lateral Epicondylitis, Unspecified Elbow
Interventions
DEVICE

Embozene particles

Embozene particles are FDA approved for the embolization of hypervascular tumors and arteriovenous malformations. Several studies have shown excellent safety and efficacy with regards to tumor control and objective response in liver cancer. It has been used extensively for the treatment of symptomatic uterine fibroids, where Embozene embolization of the uterine arteries results in necrosis of uterine fibroids and cessation of abnormal vaginal bleeding. Other proven uses include embolization of arteriovenous malformations and fistulas.

Trial Locations (1)

90095

RECRUITING

University of California, Los Angeles, Los Angeles

All Listed Sponsors
lead

Siddharth Padia, MD

OTHER